In more recent studies, rhabdomyosarcoma is therefore classified as either FOXO1 fusion positive or fusion negative; patients with fusion positive tumours have a poorer prognosis [14, 15, 33, 34]. The gene discussed is FOXO1; the disease is neoplasm.